MarketParabacteroides
Company Profile

Parabacteroides

Parabacteroides is a Gram-negative, anaerobic, non-spore-forming genus from the family Tannerellaceae.

Taxonomy
The taxon ID number used for prokaryotic genus Parabacteroides is 516255. Parent taxon comes from bacterial family Tannerellaceae, identified by number 29533 in the online LPSN database. == Genomics ==
Genomics
The genomes of Parabacteroides are highly variable, both across species and within a single strain. For example, genomes isolated from type strain P. distasonis range in size from approximately 4.5 to 5.2 Mb (megabases) and encode over 2,000 functional proteins, signifying substantial variation within the species. == Species ==
Species
The genus Parabacteroides comprises the following species, 11 of which are listed by the List of Prokaryotic names with Standing in Nomenclature (LPSN) as validly published: == Role in the human gut microenvironment ==
Role in the human gut microenvironment
Part of the bacterial order Bacteroidales present in the human gut, Parabacteroides are commonly found within the gut microenvironment. Parabacteroides species constitute a significant component of microbiota along the digestive tract, benefitting from a commensal relationship with the human body. Intestinal microbiota also benefit the human host, modulating essential metabolism-related processes within the gut microenvironment. Parabacteroides distasonis and P. goldsteinii in particular form biofilms in the gut microbiota, allowing these species to survive under harsh conditions and maintain ample populations in extreme pH environments. Recent studies elucidate new applications of Parabacteroides as probiotics, supporting balanced microbiota composition as a benefit to human digestive health. Both P. distasonis and P. goldsteinii exhibit anti-obesity effects via production of secondary bile acids and succinate within the gut microenvironment. Studies on Parabacteroides species P. distasonis reveal metabolic benefits of this mechanism, including control of weight gain, decrease in hyperglycemia, and amelioration of hepatic steatosis and other metabolic diseases. == References ==
tickerdossier.comtickerdossier.substack.com